logo

For the Inventor, By the Inventor

Stamford, CT, United States of America

Purdue Pharma L.p.


USPTO Granted Patents = 547

% Expired Patents = 25.4



Trademarks = 15

Forward Citations = 9,757

Loading Chart...
Loading Chart...

193 inventors (with patents filed for the assignee):

goldMedal Benjamin Oshlack (118 out of 157 patents)

silverMedal Laykea Tafesse (84 out of 91 patents)

bronzeMedal Curtis Wright (74 out of 86 patents)

4.  Donald Kyle (66 out of 338 patents)

5.  Haiyong Hugh Huang (62 out of 63 patents)

6.  Christopher D Breder (46 out of 57 patents)

7.  Richard O Mannion (42 out of 43 patents)

8.  Edward P O'Donnell (41 out of 42 patents)

9.  Jiangchao Yao (41 out of 50 patents)

10.  William H McKenna (40 out of 41 patents)

11.  Hua-Pin Huang (39 out of 48 patents)

12.  John K Masselink (36 out of 37 patents)

13.  Alfred P Tonelli (34 out of 35 patents)

14.  Qun Sun (29 out of 92 patents)

15.  Richard S Sackler (27 out of 48 patents)


Core Competencies:
Tamper Resistant
Opioid Treatments
Pharmaceutical Formulations
Sleep Disorders
Lymphoma Compounds
TNBC
Morphinan Derivatives
Tinostamustine
Attention Deficit Disorder
Controlled Release
Oxycodone
TRPV1 Antagonists

547 patents:

1. 12653808 - Compounds for treating multiple myeloma (2026-06-16),
2. 12582647 - Systems and methods for treating an opioid-induced adverse pharmacodynamic response (2026-03-24),
3. 12396955 - Tamper resistant dosage forms (2025-08-26),
4. 12377076 - Compounds for treating lymphoma or a T-cell malignant disease (2025-08-05),
5. 12371427 - Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound (2025-07-29),
6. 12370191 - Treatment and prevention of sleep disorders (2025-07-29),
7. 12370178 - Tinostamustine for use in the treatment of t-cell prolymphocytic leukaemia (2025-07-29),
8. 12303492 - Compounds for treating TNBC (2025-05-20),
9. 12297199 - Morphinan derivatives and use thereof (2025-05-13),
10. 12280152 - Tamper resistant dosage forms (2025-04-21),
11. 12257237 - Tinostamustine for use in treating sarcoma (2025-03-25),
12. 12246094 - Tamper resistant dosage forms (2025-03-11),
13. 12201629 - Method of treatment and dosage forms thereof (2025-01-21),
14. 12171762 - Sleep disorder treatment and prevention (2024-12-24),
15. 12161754 - Abuse deterrent morphine sulfate dosage forms (2024-12-10),
Purdue Pharma L.P. is a pharmaceutical company dedicated to improving patients' lives through the development and commercialization of innovative medicines. With a focus on pain management and related therapeutic areas, they aim to address unmet medical needs. Headquartered in Stamford, Connecticut, Purdue Pharma operates worldwide, collaborating with healthcare professionals and institutions to provide effective treatment options and enhance patient outcomes.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Purdue Pharma L.p.
547 Patents

#8 in Stamford, CT

#31 in Connecticut

#892 in US

#1,770 in the World

Stamford, CT (US)
Stamford, CT, United States of America

Purdue Pharma L.p.

Forward Citations = 9,757

193 inventors:

goldMedal Benjamin Oshlack (118 out of 157 patents)

silverMedal Laykea Tafesse (84 out of 91 patents)

bronzeMedal Curtis Wright (74 out of 86 patents)

4.  Donald Kyle (66 out of 338 patents)

5.  Haiyong Hugh Huang (62 out of 63 patents)

Please report any incorrect information to [email protected]
Loading…